The expression of both CD44 and GABRP was upregulated in pancreatic gemcitabine resistant cells and tumor tissues compared to the null resistant cells and normal tissues, and they were significantly co-expressed in patients with pancreatic cancer. Here, CD44 is linked to pancreatic neoplasm.